Potential for cytokine and product manipulation to improve the results of autologous stem cell transplantation for rheumatoid arthritis.
D017209:Apoptosis / Q000502:physiology; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D016516:CD4-CD8 Ratio; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000378:metabolism*; D053222:Fas Ligand Protein; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D008562:Membrane Glycoproteins / Q000378:metabolism; D009000:Monocytes / Q000276:immunology; D019172:Transplantation Conditioning; D023001:Transplantation Tolerance / Q000187:drug effects; D014182:Transplantation, Autologous; D016896:Treatment Outcome